Orion Market Research (OMR) recently published a market research report on the Global Diabetic Nephropathy Market. According to OMR analysis, Global Diabetic Nephropathy Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The factors contributing to the growth of the Global Diabetic Nephropathy Market include sedentary lifestyle and faulty dietary habits and increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth.

Furthermore, Global Diabetic Nephropathy Market is segmented on the basis of indication, by diagnosis type, by treatment type, by end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

A full report of the global diabetic nephropathy market at: https://www.omrglobal.com/industry-reports/diabetic-nephropathy-market/

Market Segmentation
1. Global diabetic nephropathy market, by indication
• Diabetes type-1
• Diabetes type-2
2. Global diabetic nephropathy market, by diagnosis type
• Urine test
• Imaging tests
• Blood test
• Renal function testing
• Renal biopsy
3. Global diabetic nephropathy market, by treatment type
• Medications
• Diuretics
• Angiotensin-converting enzyme inhibitors
• Antioxidant inflammation modulator
• Angiotensin receptor blockers
• Renin inhibitors
• Calcium channel blockers
• Others (monocyte chemoattractant proteins inhibitor and g protein-coupled receptors)
• Kidney dialysis
• Kidney transplant
• Acupuncture
4. Global diabetic nephropathy market by End-User
• Hospital & clinic
• Diagnostic center
•Research institutes

Visit here to know more about Global Diabetic Nephropathy Market study.

Region Covered
• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profile
• Abbott laboratories
• Abbvie Inc.
• Aerpio
• Antisense therapeutics ltd.
• Astellas pharma, Inc.
• Astrazeneca
• Bayer AG
• Bristol-Myers Squibb company
• Cellmid ltd.
• Chemocentryx, Inc.
• Concert pharmaceuticals, Inc.
• Daiichi Sankyo Company, ltd.
• Diamedica therapeutics, Inc.
• Dimerix
• Dong WHA pharma co., ltd.
• Eli Lilly and company
• Evotec AG
• Galectin therapeutics Inc.
• Genkyotex.com
• Gilead
• Glaxosmithkline PLC.
• Glucox biotech
• Gni group ltd.
• Intercept pharmaceuticals, Inc.
• Inventiva pharma
• Jenrin discovery
• Johnson & Johnson services, Inc.
• Mesoblast ltd
• Mitsubishi Tanabe pharma Europe ltd.
• Noxxon pharma
• Xortx therapeutics Inc.

For Free Sample reports please visit: https://www.omrglobal.com/request-sample/?id=17864

Related Reports:
• Weight Management Market
• Diabetic Footwear Market

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667,+91 780-304-0404